Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from <named-content content-type="genus-species">Cryptococcus gattii</named-content> Independently of T Cells

ABSTRACT Cryptococcus neoformans causes deadly mycosis primarily in AIDS patients, whereas Cryptococcus gattii infects mostly non-HIV patients, even in regions with high burdens of HIV/AIDS and an established environmental presence of C. gattii. As HIV induces type I IFN (t1IFN), we hypothesized tha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michael J. Davis, Shannon Moyer, Elizabeth S. Hoke, Edward Sionov, Katrin D. Mayer-Barber, Dan L. Barber, Hongyi Cai, Lisa Jenkins, Peter J. Walter, Yun C. Chang, Kyung J. Kwon-Chung
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
HIV
Acceso en línea:https://doaj.org/article/ab76c103e8fd408b9740ad489cd574c4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ab76c103e8fd408b9740ad489cd574c4
record_format dspace
spelling oai:doaj.org-article:ab76c103e8fd408b9740ad489cd574c42021-11-15T15:55:24ZPulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from <named-content content-type="genus-species">Cryptococcus gattii</named-content> Independently of T Cells10.1128/mBio.00799-192150-7511https://doaj.org/article/ab76c103e8fd408b9740ad489cd574c42019-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00799-19https://doaj.org/toc/2150-7511ABSTRACT Cryptococcus neoformans causes deadly mycosis primarily in AIDS patients, whereas Cryptococcus gattii infects mostly non-HIV patients, even in regions with high burdens of HIV/AIDS and an established environmental presence of C. gattii. As HIV induces type I IFN (t1IFN), we hypothesized that t1IFN would differentially affect the outcome of C. neoformans and C. gattii infections. Exogenous t1IFN induction using stabilized poly(I·C) (pICLC) improved murine outcomes in either cryptococcal infection. In C. neoformans-infected mice, pICLC activity was associated with C. neoformans containment and classical Th1 immunity. In contrast, pICLC activity against C. gattii did not require any immune factors previously associated with C. neoformans immunity: T, B, and NK cells, IFN-γ, and macrophages were all dispensable. Interestingly, C. gattii pICLC activity depended on β-2-microglobulin, which impacts iron levels among other functions. Iron supplementation reversed pICLC activity, suggesting C. gattii pICLC activity requires iron limitation. Also, pICLC induced a set of iron control proteins, some of which were directly inhibitory to cryptococcus in vitro, suggesting t1IFN regulates iron availability in the pulmonary air space fluids. Thus, exogenous induction of t1IFN significantly improves the outcome of murine infection by C. gattii and C. neoformans but by distinct mechanisms; the C. gattii effect was mediated by iron limitation, while the effect on C. neoformans infection was through induction of classical T-cell-dependent immunity. Together this difference in types of T-cell-dependent t1IFN immunity for different Cryptococcus species suggests a possible mechanism by which HIV infection may select against C. gattii but not C. neoformans. IMPORTANCE Cryptococcus neoformans and Cryptococcus gattii cause fatal infection in immunodeficient and immunocompetent individuals. While these fungi are sibling species, C. gattii infects very few AIDS patients, while C. neoformans infection is an AIDS-defining illness, suggesting that the host response to HIV selects C. neoformans over C. gattii. We used a viral mimic molecule (pICLC) to stimulate the immune response, and pICLC treatment improved mouse outcomes from both species. pICLC-induced action against C. neoformans was due to activation of well-defined immune pathways known to deter C. neoformans, whereas these immune pathways were dispensable for pICLC treatment of C. gattii. Since these immune pathways are eventually destroyed by HIV/AIDS, our data help explain why the antiviral immune response in AIDS patients is unable to control C. neoformans infection but is protective against C. gattii. Furthermore, pICLC induced tighter control of iron in the lungs of mice, which inhibited C. gattii, thus suggesting an entirely new mode of nutritional immunity activated by viral signals.Michael J. DavisShannon MoyerElizabeth S. HokeEdward SionovKatrin D. Mayer-BarberDan L. BarberHongyi CaiLisa JenkinsPeter J. WalterYun C. ChangKyung J. Kwon-ChungAmerican Society for MicrobiologyarticleCryptococcus gattiiCryptococcus neoformansHIVMDA-5interferonsironMicrobiologyQR1-502ENmBio, Vol 10, Iss 3 (2019)
institution DOAJ
collection DOAJ
language EN
topic Cryptococcus gattii
Cryptococcus neoformans
HIV
MDA-5
interferons
iron
Microbiology
QR1-502
spellingShingle Cryptococcus gattii
Cryptococcus neoformans
HIV
MDA-5
interferons
iron
Microbiology
QR1-502
Michael J. Davis
Shannon Moyer
Elizabeth S. Hoke
Edward Sionov
Katrin D. Mayer-Barber
Dan L. Barber
Hongyi Cai
Lisa Jenkins
Peter J. Walter
Yun C. Chang
Kyung J. Kwon-Chung
Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from <named-content content-type="genus-species">Cryptococcus gattii</named-content> Independently of T Cells
description ABSTRACT Cryptococcus neoformans causes deadly mycosis primarily in AIDS patients, whereas Cryptococcus gattii infects mostly non-HIV patients, even in regions with high burdens of HIV/AIDS and an established environmental presence of C. gattii. As HIV induces type I IFN (t1IFN), we hypothesized that t1IFN would differentially affect the outcome of C. neoformans and C. gattii infections. Exogenous t1IFN induction using stabilized poly(I·C) (pICLC) improved murine outcomes in either cryptococcal infection. In C. neoformans-infected mice, pICLC activity was associated with C. neoformans containment and classical Th1 immunity. In contrast, pICLC activity against C. gattii did not require any immune factors previously associated with C. neoformans immunity: T, B, and NK cells, IFN-γ, and macrophages were all dispensable. Interestingly, C. gattii pICLC activity depended on β-2-microglobulin, which impacts iron levels among other functions. Iron supplementation reversed pICLC activity, suggesting C. gattii pICLC activity requires iron limitation. Also, pICLC induced a set of iron control proteins, some of which were directly inhibitory to cryptococcus in vitro, suggesting t1IFN regulates iron availability in the pulmonary air space fluids. Thus, exogenous induction of t1IFN significantly improves the outcome of murine infection by C. gattii and C. neoformans but by distinct mechanisms; the C. gattii effect was mediated by iron limitation, while the effect on C. neoformans infection was through induction of classical T-cell-dependent immunity. Together this difference in types of T-cell-dependent t1IFN immunity for different Cryptococcus species suggests a possible mechanism by which HIV infection may select against C. gattii but not C. neoformans. IMPORTANCE Cryptococcus neoformans and Cryptococcus gattii cause fatal infection in immunodeficient and immunocompetent individuals. While these fungi are sibling species, C. gattii infects very few AIDS patients, while C. neoformans infection is an AIDS-defining illness, suggesting that the host response to HIV selects C. neoformans over C. gattii. We used a viral mimic molecule (pICLC) to stimulate the immune response, and pICLC treatment improved mouse outcomes from both species. pICLC-induced action against C. neoformans was due to activation of well-defined immune pathways known to deter C. neoformans, whereas these immune pathways were dispensable for pICLC treatment of C. gattii. Since these immune pathways are eventually destroyed by HIV/AIDS, our data help explain why the antiviral immune response in AIDS patients is unable to control C. neoformans infection but is protective against C. gattii. Furthermore, pICLC induced tighter control of iron in the lungs of mice, which inhibited C. gattii, thus suggesting an entirely new mode of nutritional immunity activated by viral signals.
format article
author Michael J. Davis
Shannon Moyer
Elizabeth S. Hoke
Edward Sionov
Katrin D. Mayer-Barber
Dan L. Barber
Hongyi Cai
Lisa Jenkins
Peter J. Walter
Yun C. Chang
Kyung J. Kwon-Chung
author_facet Michael J. Davis
Shannon Moyer
Elizabeth S. Hoke
Edward Sionov
Katrin D. Mayer-Barber
Dan L. Barber
Hongyi Cai
Lisa Jenkins
Peter J. Walter
Yun C. Chang
Kyung J. Kwon-Chung
author_sort Michael J. Davis
title Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from <named-content content-type="genus-species">Cryptococcus gattii</named-content> Independently of T Cells
title_short Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from <named-content content-type="genus-species">Cryptococcus gattii</named-content> Independently of T Cells
title_full Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from <named-content content-type="genus-species">Cryptococcus gattii</named-content> Independently of T Cells
title_fullStr Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from <named-content content-type="genus-species">Cryptococcus gattii</named-content> Independently of T Cells
title_full_unstemmed Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from <named-content content-type="genus-species">Cryptococcus gattii</named-content> Independently of T Cells
title_sort pulmonary iron limitation induced by exogenous type i ifn protects mice from <named-content content-type="genus-species">cryptococcus gattii</named-content> independently of t cells
publisher American Society for Microbiology
publishDate 2019
url https://doaj.org/article/ab76c103e8fd408b9740ad489cd574c4
work_keys_str_mv AT michaeljdavis pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT shannonmoyer pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT elizabethshoke pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT edwardsionov pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT katrindmayerbarber pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT danlbarber pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT hongyicai pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT lisajenkins pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT peterjwalter pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT yuncchang pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
AT kyungjkwonchung pulmonaryironlimitationinducedbyexogenoustypeiifnprotectsmicefromnamedcontentcontenttypegenusspeciescryptococcusgattiinamedcontentindependentlyoftcells
_version_ 1718427168505069568